Are CTCs A Reliable Metric for Patient Stratification in Cancer?
It is still unknown whether liquid biopsies are a reliable mechanism for determining disease prognosis outside of prostate cancer.
Prostate Cancer
Urine Biomarker Helps Classify Risk Level in Prostate Cancer
Urine-derived extracellular vesicle RNA provides diagnostic, prognostic information in prostate cancer.
Routine mpMRI Use Leads to Earlier Treatment of Men on Prostate Cancer AS
Men on active surveillance for prostate cancer progress to treatment sooner if they undergo multiparametric MRI to identify clinically significant tumors.
Prostate Cancer Salvage Cryotherapy May Offer Durable Tumor Control
In a study, patients who underwent salvage cryotherapy for radiorecurrent prostate cancer had cancer-specific and metastasis-free survival rates of 81% and 78%, respectively, at 12 years.
Fragmentation Pattern of Cell-Free DNA Can Reveal Cancer, Even at Early Stages
Machine learning algorithm detected 7 types of cancer in liquid biopsy and identified tissue of disease origin.
Solving the Obesity Paradox in Oncology
One potentially revolutionary hypothesis relates to the evolutionary processes involved in oncogenesis.
Prostate Cancer Salvage Surgery, Ablation Offer Similar Outcomes
Radical prostatectomy and ablation for salvage treatment of radiorecurrent prostate cancer do not differ significant with regard to cancer-specific and metastasis-free survival, a study found.
Combination Biopsy Strategy May Identify More Prostate Cancers
A lesion visible on magnetic resonance imaging (MRI) identifies a heightened risk for clinically significant prostate cancer in men undergoing first-time prostate biopsy, and a combination of targeted and systematic biopsy may improve the chances of detecting cancer.
Alcohol and Prostate Cancer: How Is Intake Associated With Risk of Death and/or Metastasis?
This data analysis examined the effect of alcohol consumption on the risk of lethal prostate cancer in men at risk of the disease, and those who developed nonmetastatic prostate cancer during follow-up.
Active Surveillance for Intermediate-Risk PCa Increasing in US
Older men with favorable intermediate-risk prostate cancer treated in the West, Northwest, or Midwest were the biggest adopters of AS during the years 2010 and 2015.
Next post in Prostate Cancer
